Lab Chat

CBTTC Announces New Executive Chair

CBTTC Announces New Executive Chair

PHILADELPHIA – The Children’s Brain Tumor Tissue Consortium (CBTTC) has announced the appointment of Rishi R. Lulla, MD, MS as its new executive chair.  Dr. Lulla is an attending physician of hematology, oncology, neuro-oncology & stem cell transplantation at Ann & Robert Lurie Children’s Hospital in Chicago, Illinois.  Dr. Lulla’s leadership and experience will ensure a continued focus on CBTTC’s innovative pediatric brain tumor research initiatives.

Rishi Lulla
Dr. Rishi Lulla, newly-appointed Executive Chair of the CBTTC

Lurie Children’s Hospital was one of the founding core member institutions of the CBTTC in 2009. Dr. Lulla, in partnership with Drs. Stewart Goldman and Jason Fangusaro, played an integral role in the development of the CBTTC’s core vision and the consortium’s continued  growth and expansion.

The CBTTC Executive Board expresses its deep gratitude for the founding contributions of former chair, Dr. Peter Phillips. Dr. Phillips has successfully led the Neuro-Oncology program at The Children’s Hospital of Philadelphia (CHOP) for the past 25 years and is stepping  down from his roles in the operations center of the CBTTC and from his leadership role as section chief of Neuro-Oncology at CHOP.  Dr. Michael Fisher has been appointed as the new section chief for Neuro-Oncology at CHOP. The Consortium enthusiastically welcomes Dr. Fisher as a member of its executive board.

“Rishi has been an amazing partner in the development of the CBTTC, and we eagerly look forward to his leadership of the executive board and continued partnership in pursuing the CBTTC’s mission of innovation through collaboration,” said Dr. Adam Resnick, scientific chair of the CBTTC.

The Children’s Brain Tumor Tissue Consortium is a multi-institutional, collaborative research partnership dedicated to improving treatments and outcomes for children diagnosed with brain tumors.  The nucleus of the CBTTC is a state-of-the-art biorepository and informatics portal, which allows researchers from all over the world to access high-quality genomic and clinical tumor data. The operations center of the CBTTC is located at The Children’s Hospital of Philadelphia, in addition to nine other member institutions throughout the world. For more information, visit cbttc.org.

Rishi R. Lulla, MD, MS is an attending physician, Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation; assistant professor of Pediatrics, Northwestern University Feinberg School of Medicine. Dr. Lulla attended medical school at The Boston University School of Medicine and is board certified in pediatric hematology-oncology and general pediatrics.  He specializes in brain and spinal cord tumors (neuro-oncology), phase I/phase II developmental therapeutics and translational research.

Download the press release – CBTTC Executive Chair Announcement – Press Release

Leave a comment

Your email address will not be published. Required fields are marked *